Skip to main content

Table 2 Baseline characteristics summarized according to subjects’ glycemic status during follow-up

From: Evaluation of the role of atherogenic index of plasma in the reversion from Prediabetes to normoglycemia or progression to Diabetes: a multi-center retrospective cohort study

 

Glucose status during follow-up

P-value

Prediabetes

NFG

Diabetes

No. of subjects

6516

6481

2424

 

Sex

   

< 0.001

Male

4358 (66.88%)

3949 (60.93%)

1702 (70.21%)

 

Female

2158 (33.12%)

2532 (39.07%)

722 (29.79%)

 

Age, years

53.00 (43.00–62.00)

46.00 (36.00–58.00)

55.00 (46.00–63.00)

< 0.001

Height, cm

166.59 (8.37)

166.71 (8.40)

166.74 (8.31)

0.625

Weight, kg

69.80 (11.81)

67.64 (12.12)

72.22 (12.60)

< 0.001

BMI, kg/m2

25.06 (3.19)

24.23 (3.28)

25.87 (3.41)

< 0.001

SBP, mmHg

129.35 (17.76)

124.16 (16.93)

131.46 (17.99)

< 0.001

DBP, mmHg

79.53 (11.24)

76.73 (10.84)

80.49 (11.31)

< 0.001

FPG, mmol/L

6.00 (0.32)

5.84 (0.24)

6.15 (0.38)

< 0.001

TC, mmol/L

5.08 (0.94)

4.99 (0.94)

5.10 (0.97)

< 0.001

TG, mmol/L

1.50 (1.04–2.20)

1.31 (0.90–1.97)

1.67 (1.14–2.45)

< 0.001

HDL-C, mmol/L

1.31 (1.13–1.51)

1.34 (1.15–1.54)

1.29 (1.09–1.50)

< 0.001

LDL-C, mmol/L

2.90 (2.46–3.36)

2.84 (2.41–3.33)

2.88 (2.43–3.40)

< 0.001

AIP

0.07 (0.30)

0.01 (0.31)

0.12 (0.30)

< 0.001

ALT, U/L

22.50 (16.00–33.00)

20.40 (14.50–31.00)

24.90 (17.80–37.00)

< 0.001

AST, U/L

24.00 (20.00-28.80)

23.50 (19.40–28.80)

25.00 (20.70–31.00)

< 0.001

BUN, mmol/L

4.91 (4.19–5.78)

4.80 (4.05–5.68)

4.93 (4.13–5.80)

< 0.001

Cr, umol/L

73.50 (62.10–84.00)

72.00 (59.80–82.90)

73.30 (62.00–83.00)

< 0.001

Family history of diabetes

151 (2.32%)

148 (2.28%)

85 (3.51%)

0.002

Smoking status

   

< 0.001

Current

577 (8.86%)

491 (7.58%)

242 (9.98%)

 

Past

94 (1.44%)

121 (1.87%)

44 (1.82%)

 

Never

1471 (22.58%)

1642 (25.34%)

481 (19.84%)

 

Not recorded

4374 (67.13%)

4227 (65.22%)

1657 (68.36%)

 

Drinking status

   

0.005

Current

100 (1.53%)

86 (1.33%)

29 (1.20%)

 

Past

342 (5.25%)

429 (6.62%)

136 (5.61%)

 

Never

1700 (26.09%)

1739 (26.83%)

602 (24.83%)

 

Not recorded

4374 (67.13%)

4227 (65.22%)

1657 (68.36%)

 
  1. Values were expressed as mean (standard deviation) or median (interquartile range) or n (%)
  2. Abbreviations: NFG: normal fasting glucose; other abbreviations as in Table 1
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840